Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;1(1):53-6.
doi: 10.4103/0976-9668.71675.

Role of antibodies in cancer targeting

Husain Attarwala  1
Affiliations

Role of antibodies in cancer targeting

Husain Attarwala. J Nat Sci Biol Med. 2010 Jul.

Abstract

The development of chemotherapeutic agents capable of specifically eliminating tumor cells has been a great challenge since these agents cannot differentiate between normal body cells and tumor cells. Enhanced elimination of cancer cells without affecting normal body cells can be achieved by developing strategies which can enable drug targeting. With recent advances in antibody engineering strategies, the development of different antibody-associated tumor-targeted delivery systems for chemotherapy, chemoprevention, and early cancer diagnosis has become possible. In this review, the role of antibodies for cancer diagnosis, chemoprevention, and chemotherapy will be discussed with an emphasis on recent advances in antibody engineering.

Keywords: Antibody engineering; cancer diagnosis; cancer targeting; chemoprevention; chemotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer. 2002;2:750–63. - PubMed
    1. Adams GP, Weiner LM. Monoclonal antibody therapy of cancer. Nat Biotechnol. 2005;23:1147–57. - PubMed
    1. Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol. 2005;23:1126–36. - PubMed
    1. Milenic DE, Brady ED, Brechbiel MW. Antibody-targeted radiation cancer therapy. Nat Rev Drug Discov. 2004;3:488–99. - PubMed
    1. Payne G. Progress in immunoconjugate cancer therapeutics. Cancer Cell. 2003;3:207–12. - PubMed

LinkOut - more resources